Open data is widely recognized as valuable, especially during the COVID-19 pandemic, highlighting the need for up-to-date information systems, leading all sectors to acknowledge its significance in enhancing efficiency, fairness, and societal development. These open data movements observed during

MEAs aim at early access to high-cost innovative medicines at pre-determined terms that can ensure the financial sustainability of healthcare systems. However, their successful adoption hinges on a consideration of various factors to address the unique challenges faced by different nations. The a

Familial Hypercholesterolemia (FH) is a genetic disorder characterized by elevated cholesterol levels, significantly increasing the risk of heart disease. Early detection through genetic screening can play a crucial role in preventing serious health outcomes. This study marks the first global eco

– The pharmaceutical industry is a significant emitter of carbon emissions, which accelerates climate change and directly affects human health and health systems. – The safety and efficacy profiles of intravenous (IV) and oral paracetamol for patients undergoing surgeries are comparable. – Swi

201-369-2555HITA,HITAP,HTA,method guidelines,การประเมินความคุ้มค่าด้านสุขภาพ

This study is a development oriented research. The data is collected by participant observation, brainstorming with experts, and a questionnaire asking opinions and the satisfaction from stakeholders attending the meeting of “the prioritization of research topics” on January 22nd, 2010. There was a total of 120 research topics proposed by 66 ag

Economic evaluation of HLA-B*1502 screening for preventing carbamazepine- induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is prioritized by stakeholders under ‘Research for development of health benefit package under universal coverage scheme’. The study carried out an evidence to inform the Subcommittee for Developm

Presently, Cost-Effectiveness Analysis has been increasingly adopted in health technology assessment. In addition, it is recognized as an important tool for policy makers in the health care resource allocation decision making process. However, the presentation of Cost-Effectiveness Analysis results in terms of cost per Quality-Adjusted Life Year (Q

Impact of obesity on economics and quality of life in Thailand  Obesity is regarded as a disease that requires appropriate treatment. At the global level, obesity is ranked the 6th among factors that cause diseases. The economic impact of obesity is substantial. The objective of this study was to estimate that healthcare cost and cost of productiv

There is an increasing impetus to use economic evaluation to allow more explicit and transparent healthcare priority setting. However, an important question for policy makers is whether it is appropriate and feasible to introduce economic evaluation data into healthcare priority setting or resource allocation decisions. This project systematically